T1	p 100 116	schizophrenics :
T2	p 272 288	schizophrenics .
T3	p 297 339	A total of 81 schizophrenics were randomly
T4	p 359 369	group with
T5	p 2513 2541	symptoms of schizophrenics .
T6	i 20 57	paliperidone extended-release tablets
T7	i 192 229	paliperidone extended-release tablets
T8	i 370 419	paliperidone extended-release tablets and control
T9	i 431 442	risperidone
T10	i 554 560	social
T11	i 593 603	SDSS ) and
T12	i 664 668	th )
T13	i 686 690	th )
T14	i 776 780	th )
T15	i 1119 1123	th )
T16	i 1249 1253	th )
T17	i 1371 1375	th )
T18	i 1739 1743	th )
T19	i 1925 1929	th )
T20	i 2012 2016	th )
T21	i 2174 2178	th )
T22	i 2417 2454	Paliperidone extended-release tablets
T23	o 65 96	improvement of social functions
T24	o 237 268	improvement of social functions
T25	o 517 581	negative symptoms scales ( PANSS ) , social disability screening
T26	o 604 643	treatment emergent symptom scale ( TESS
T27	o 664 683	th ) weekend and 12
T28	o 686 700	th ) weekend .
T29	o 738 763	and total scores of PANSS
T30	o 776 788	th ) weekend
T31	o 792 801	treatment
T32	o 1056 1062	factor
T33	o 1065 1106	negative factor and total scores of PANSS
T34	o 1119 1131	th ) weekend
T35	o 1135 1144	treatment
T36	o 1249 1261	th ) weekend
T37	o 1265 1274	treatment
T38	o 1371 1386	th ) weekend of
T39	o 1411 1436	and total scores of PANSS
T40	o 1706 1726	total scores of SDSS
T41	o 1739 1754	th ) weekend of
T42	o 1779 1780	)
T43	o 1892 1912	total scores of SDSS
T44	o 1925 1940	th ) weekend of
T45	o 1963 1964	)
T46	o 2012 2027	th ) weekend of
T47	o 2174 2189	th ) weekend of
T48	o 2206 2226	total scores of SDSS
T49	o 2254 2255	)
T50	o 2353 2374	severe adverse effect
T51	o 2472 2521	improve social functions and psychiatric symptoms